"The U.S. Food and Drug Administration today approved Farydak (panobinostat) for the treatment of patients with multiple myeloma.
Multiple myeloma is a form of blood cancer that arises from plasma cells, a type of white blood cell, found in "...
Rituxan Patient Information including How Should I Take
In this Article
- What is rituximab (Rituxan)?
- What are the possible side effects of rituximab (Rituxan)?
- What is the most important information I should know about rituximab (Rituxan)?
- What should I discuss with my healthcare provider before receiving rituximab (Rituxan)?
- How is rituximab given (Rituxan)?
- What happens if I miss a dose (Rituxan)?
- What happens if I overdose (Rituxan)?
- What should I avoid while receiving rituximab (Rituxan)?
- What other drugs will affect rituximab (Rituxan)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving rituximab (Rituxan)?
You should not receive this medication if you have ever had a severe allergic reaction to rituximab, or if you are allergic to mouse protein.
To make sure you can safely use rituximab, tell your doctor if you have any of these other conditions:
- liver disease or hepatitis B (or if you are a carrier of hepatitis B);
- kidney disease;
- systemic lupus erythematosus (SLE);
- lung disease or a breathing disorder;
- a weak immune system (caused by disease or by using certain medicines);
- a recent or active infection, including herpes, shingles, cytomegalovirus, chickenpox, parvovirus, West Nile virus, hepatitis C, or any infection that keeps coming back or does not clear up;
- a history of heart disease, angina (chest pain), or heart rhythm disorder; or
- if you have used certain arthritis medicines in the past that were not effective, including adalimumab (Humira), certolizumab (Cimzia), golimumab (Simponi), etanercept (Enbrel), or infliximab (Remicade).
FDA pregnancy category C. It is not known whether rituximab will harm an unborn baby. Rituximab can affect the immune system of a newborn if the mother receives the medication during pregnancy. Tell your doctor if you are pregnant or plan to become pregnant. Use effective birth control while you are using this medication and for at least 12 months after your treatment ends.
It is not known whether rituximab passes into breast milk or if it could harm a nursing baby. Do not receive rituximab without telling your doctor if you are breast feeding a baby.
How is rituximab given (Rituxan)?
Rituximab is injected into a vein through an IV. A healthcare provider will give you this injection. Follow your doctor's dosing instructions very carefully.
Before you receive rituximab, you may be given other medications to prevent certain side effects that rituximab can cause.
If you need surgery, tell the surgeon ahead of time that you are using rituximab.
While using rituximab, you may need frequent blood tests at your doctor's office.
If you have hepatitis B you may develop liver symptoms after you stop using this medication, even months after stopping. Your doctor may want to check your liver function for several months after you stop using rituximab.
Additional Rituxan Information
- Rituxan Drug Interactions Center: rituximab iv
- Rituxan Side Effects Center
- Rituxan Overview including Precautions
- Rituxan FDA Approved Prescribing Information including Dosage
Rituxan - User Reviews
Rituxan User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.